News RetinalGenix Technologies Inc.

Equities

RTGN

US76133Y1055

Delayed OTC Markets Other stock markets 12:47:02 2024-02-22 pm EST			5-day change	1st Jan Change
3.5 ^USD	+12.90%		-.--%	+13.27%

Apr. 01	RetinalGenix Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 09	RetinalGenix Technologies Inc. announced that it has received $4.65 million in funding	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RetinalGenix Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
RetinalGeniX™ Technologies Inc. Granted a Patent for System And Method For Visualization Of Ocular Anatomy	Feb. 22	GL
RetinalGeniX™ Technologies Inc. Granted a Patent for System And Method For Visualization Of Ocular Anatomy	Feb. 22	AQ
RetinalGenix Technologies Inc. announced that it has received $4.65 million in funding	Feb. 08	CI
RetinalGenix Technologies Inc. announced that it expects to receive $4.65 million in funding	Jan. 22	CI
RetinalGeniX™ Technologies Inc. Contracts With MEDsan, Inc. to Provide Diagnostic Testing Services for Its Institutional Review Board to Conduct a Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration	Dec. 26	GL
RetinalGeniX?? Technologies Inc. Contracts with Medsan, Inc. to Provide Diagnostic Testing Services for Its Institutional Review Board to Conduct a Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration	Dec. 26	CI
RetinalGeniX Technologies Inc. Appoints Anatoly Dritschilo, M.D. to the Company’s Medical Advisory Board	Dec. 21	GL
RetinalGeniX Technologies Inc. Appoints Anatoly Dritschilo, M.D. to the Company’s Medical Advisory Board	Dec. 21	AQ
RetinalGeniX Technologies Inc. Appoints Anatoly Dritschilo, M.D. to the Medical Advisory Board	Dec. 21	CI
RetinalGeniX Technologies Inc. Appoints Dessy Boneva, MD, FACS to the Board of Directors	Dec. 04	GL
RetinalGeniX Technologies Inc. Appoints Dessy Boneva, MD, FACS to the Board of Directors	Dec. 04	AQ
RetinalGeniX Technologies Inc. Appoints Dessislava Boneva to its Board of Directors	Dec. 04	CI
RetinalGeniX Technologies Inc. Announces Hiring of Interim CFO	Dec. 01	GL
RetinalGenix Technologies Inc. Appoints Virender Ahluwalia as Interim Chief Financial Officer	Dec. 01	CI
RetinalGeniX Technologies Inc. Appoints Stephen Tannenbaum to the Company's Business Advisory Board	Nov. 28	GL
RetinalGeniX Technologies Inc. Appoints Stephen Tannenbaum to the Company's Business Advisory Board	Nov. 28	AQ
RetinalGenix Technologies Inc. Appoints Stephen Tannenbaum to the Business Advisory Board	Nov. 28	CI
RetinalGenix Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
RetinalGeniX™ Technologies Inc. Announces the Submission of Two Provisional Patent Applications For Investigational Therapeutic Drugs	Nov. 09	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News RetinalGenix Technologies Inc.

Equities

RTGN

US76133Y1055

Summary

Filters